Prevention of Doxorubicin Cardiopathic Changes by a Benzyl Styryl Sulfone in Mice

Genes and Cancer

Volumn 2, Issue 10, 2011, Pages 985-992

  Lu, Min ^a   Merali, Salim ^b   Gordon, Ronald ^a   Jiang, Jiandong ^a,c   Li, Yan ^a   Mandeli, John ^a   Duan, Xunbao ^b   Fallon, John ^a,d   Holland, James F ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PEKING UNION MEDICAL COLLEGE   (China)

^d NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

cardiotoxicity; chemotherapy; doxorubicin; glucose responsive protein; protein folding

Indexed keywords

DOXORUBICIN; GLUCOSE REGULATED PROTEIN 78; ON 1910; RIGOSERTIB; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CARDIOTOXICITY; CONTROLLED STUDY; DRUG POTENTIATION; DRUG STRUCTURE; ELECTRON MICROSCOPY; FEMALE; HEART PROTECTION; HEART WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT;

MUS; MUS MUSCULUS;

EID: 84868642290     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601911436199     Document Type: Article

References (37)

1. Ibrahim NK,Hortobagyi GN,Ewer M, et al.Doxorubicin-induced congestive heart failure in elderly patients with metastatic breast cancer, with long-term follow-up: the M.D. Anderson experience.Cancer Chemother Pharmacol. 1999;43:471-8.
2. Pein F,Sakiroglu O,Dahan M, et al.Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy.Br J Cancer. 2004;91:37-44.
3. Billingham ME,Bristow MR,Glatstein E,Mason JW,Masek MA,Daniels JR.Adriamycin cardiotoxicity: endomyocardial biopsy evidence of enhancement by irradiation.Am J Surg Pathol. 1977;1:17-23.
4. Gianni L,Salvatorelli E,Minotti G.Anthracycline cardiotoxicity in breast cancer patients: synergism with trastuzumab and taxanes.Cardiovasc Toxicol. 2007;7:67-71.
5. Russell SD,Blackwell KL,Lawrence J, et al.Independent adjudication of symptomatic heart failure with the use of doxorubicin and cyclophosphamide followed by trastuzumab adjuvant therapy: a combined review of cardiac data from the National Surgical Adjuvant Breast and Bowel Project B-31 and the North Central Cancer Treatment Group N9831 clinical trials.J Clin Oncol. 2010;28:3416-21.
6. Minotti G,Menna P,Salvatorelli E,Cairo G,Gianni L.Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity.Pharmacol Rev. 2004;56:185-229.
7. Chatterjee K,Zhang J,Honbo N,Karliner JS.Doxorubicin cardiomyopathy.Cardiology. 2010;115:155-62.
8. Alberts DS,Muggia FM,Carmichael J, et al.Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials.Semin Oncol. 2004;31:53-90.
9. Speyer JL,Green MD,Zeleniuch-Jacquotte A, et al.ICRF-187 permits longer treatment with doxorubicin in women with breast cancer.J Clin Oncol. 1992;10:117-27.
10. Swain SM,Whaley FS,Gerber MC, et al.Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.J Clin Oncol. 1997;15:1318-32.
11. Reddy MV,Mallireddigari MR,Cosenza SC, et al.Design, synthesis, and biological evaluation of (E)-styrylbenzylsulfones as novel anticancer agents.J Med Chem. 2008;51:86-100.
12. Gumireddy K,Reddy MV,Cosenza SC, et al.ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent.Cancer Cell. 2005;7:275-86.
13. Oussenko I,Holland JF,Reddy EP,Ohnuma T.ON 01910.Na, a clinical stage anticancer mitotic inhibitor, produces prolonged hyperphosphorylation of RanGAP1·SUMO1 as a potential mechanism of G2/M arrest and apoptosis.Cancer Res. 2011;71:4968-76.
14. Merksamer PI,Papa FR.The UPR and cell fate at a glance.J Cell Sci. 2010;123:1003-6.
15. Merksamer PI,Trusina A,Papa FR.Real-time redox measurements during endoplasmic reticulum stress reveal interlinked protein folding functions.Cell. 2008;135:933-47.
16. Schroder M,Kaufman RJ.ER stress and the unfolded protein response.Mutat Res. 2005;569:29-63.
17. Schroder M,Kaufman RJ.The mammalian unfolded protein response.Annu Rev Biochem. 2005;74:739-89.
18. Malhotra JD,Kaufman RJ.The endoplasmic reticulum and the unfolded protein response.Semin Cell Dev Biol. 2007;18:716-31.
19. Gorlach A,Klappa P,Kietzmann T.The endoplasmic reticulum: folding, calcium homeostasis, signaling, and redox control.Antioxid Redox Signal. 2006;8:1391-418.
20. Marciniak SJ,Ron D.Endoplasmic reticulum stress signaling in disease.Physiol Rev. 2006;86:1133-49.
21. Szegezdi E,Logue SE,Gorman AM,Samali A.Mediators of endoplasmic reticulum stress-induced apoptosis.EMBO Rep. 2006;7:880-5.
22. Ron D,Walter P.Signal integration in the endoplasmic reticulum unfolded protein response.Nat Rev Mol Cell Biol. 2007;8:519-29.
23. Scriven P,Coulson S,Haines R,Balasubramanian S,Cross S,Wyld L.Activation and clinical significance of the unfolded protein response in breast cancer.Br J Cancer. 2009;101:1692-8.
24. So AY,de la Fuente E,Walter P,Shuman M,Bernales S.The unfolded protein response during prostate cancer development.Cancer Metastasis Rev. 2009;28:219-23.
25. Foufelle F,Ferre P.Unfolded protein response: its role in physiology and physiopathology.Med Sci (Paris). 2007;23:291-6.
26. Suzuki T,Lu J,Zahed M,Kita K,Suzuki N.Reduction of GRP78 expression with siRNA activates unfolded protein response leading to apoptosis in HeLa cells.Arch Biochem Biophys. 2007;468:1-14.
27. Wu S,Ko YS,Teng MS, et al.Adriamycin-induced cardiomyocyte and endothelial cell apoptosis: in vitro and in vivo studies.J Mol Cell Cardiol. 2002;34:1595-607.
28. Kim SJ,Park KM,Kim N,Yeom YI.Doxorubicin prevents endoplasmic reticulum stress-induced apoptosis.Biochem Biophys Res Commun. 2006;339:463-8.
29. Freiden PJ,Gaut JR,Hendershot LM.Interconversion of three differentially modified and assembled forms of BiP.EMBO J. 1992;11:63-70.
30. Gething M-J.Role and regulation of the ER chaperone BiP.Cell Dev Biol. 1999;10:465-72.
31. Laitusis AL,Brostrom MA,Brostrom CO.The dynamic role of GRP78/BiP in the coordination of mRNA translation with protein processing.J Biol Chem. 1999;274:486-93.
32. Leno GH,Ledford BE.ADP-ribosylation of the 78-kDa glucose-regulated protein during nutritional stress.Eur J Biochem. 1989;186:205-11.
33. Ledford BE,Leno GH.ADP-ribosylation of the molecular chaperone GRP78/BiP.Mol Cell Biochem. 1994;138:141-8.
34. Faitova J,Krekac D,Hrstka R,Vojtesek B.Endoplasmic reticulum stress and apoptosis.Cell Mol Biol Lett. 2006;11:488-505.
35. Lin JH,Li H,Yasumura D, et al.IRE1 signaling affects cell fate during the unfolded protein response.Science. 2007;318:944-9.
36. Lai HC,Yeh YC,Ting CT, et al.Doxycycline suppresses doxorubicin-induced oxidative stress and cellular apoptosis in mouse hearts.Eur J Pharmacol. 2010;644:176-87.
37. Rutkowski DT,Arnold SM,Miller CN, et al.Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins.PLoS Biol. 2006;4:e374.